{"id":"https://openalex.org/W2808356540","doi":"https://doi.org/10.1007/s40261-018-0665-x","title":"Pharmacokinetics of a Novel Sildenafil Orodispersible Film Administered by the Supralingual and the Sublingual Route to Healthy Men","display_name":"Pharmacokinetics of a Novel Sildenafil Orodispersible Film Administered by the Supralingual and the Sublingual Route to Healthy Men","publication_year":2018,"publication_date":"2018-06-16","ids":{"openalex":"https://openalex.org/W2808356540","doi":"https://doi.org/10.1007/s40261-018-0665-x","mag":"2808356540","pmid":"https://pubmed.ncbi.nlm.nih.gov/29909432","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6061399"},"language":"en","primary_location":{"id":"doi:10.1007/s40261-018-0665-x","doi":"https://doi.org/10.1007/s40261-018-0665-x","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40261-018-0665-x","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40261-018-0665-x.pdf","source":{"id":"https://openalex.org/S138241747","display_name":"Clinical Drug Investigation","issn_l":"0114-2402","issn":["0114-2402","1173-2563","1179-1918","2196-4920"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Drug Investigation","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s40261-018-0665-x.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030190033","display_name":"Luca Loprete","orcid":"https://orcid.org/0000-0001-7616-6232","observed_orcids":["https://orcid.org/0000-0001-7616-6232"]},"institutions":[{"id":"https://openalex.org/I4405267631","display_name":"CROSS Research SA (Switzerland)","ror":"https://ror.org/03nqjwm69","country_code":"CH","type":"company","lineage":["https://openalex.org/I4405267631"]}],"countries":["CH"],"is_corresponding":true,"raw_author_name":"Luca Loprete","raw_affiliation_strings":["CROSS Research S.A., Via F.A. Giorgioli 14, 6864, Arzo, Switzerland. luca.loprete@croalliance.com","CROSS Research S.A., Arzo, Switzerland"],"raw_orcid":"https://orcid.org/0000-0001-7616-6232","affiliations":[{"raw_affiliation_string":"CROSS Research S.A., Via F.A. Giorgioli 14, 6864, Arzo, Switzerland. luca.loprete@croalliance.com","institution_ids":["https://openalex.org/I4405267631"]},{"raw_affiliation_string":"CROSS Research S.A., Arzo, Switzerland","institution_ids":["https://openalex.org/I4405267631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082249757","display_name":"Chiara Leuratti","orcid":"https://orcid.org/0000-0001-5594-6029","observed_orcids":["https://orcid.org/0000-0001-5594-6029"]},"institutions":[{"id":"https://openalex.org/I4405267631","display_name":"CROSS Research SA (Switzerland)","ror":"https://ror.org/03nqjwm69","country_code":"CH","type":"company","lineage":["https://openalex.org/I4405267631"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Chiara Leuratti","raw_affiliation_strings":["CROSS Research S.A., Via F.A. Giorgioli 14, 6864, Arzo, Switzerland","CROSS Research S.A., Arzo, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CROSS Research S.A., Via F.A. Giorgioli 14, 6864, Arzo, Switzerland","institution_ids":["https://openalex.org/I4405267631"]},{"raw_affiliation_string":"CROSS Research S.A., Arzo, Switzerland","institution_ids":["https://openalex.org/I4405267631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033185007","display_name":"Valeria Frangione","orcid":"https://orcid.org/0000-0003-0465-8953","observed_orcids":["https://orcid.org/0000-0003-0465-8953"]},"institutions":[{"id":"https://openalex.org/I4210152331","display_name":"IBSA Institut Biochimique (Switzerland)","ror":"https://ror.org/051tj3a26","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210152331"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Valeria Frangione","raw_affiliation_strings":["IBSA Institut Biochimque S.A., Via del Piano, 6915, Pambio-Noranco, Lugano, Switzerland","IBSA Institut Biochimque S.A., Pambio-Noranco, Lugano, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IBSA Institut Biochimque S.A., Via del Piano, 6915, Pambio-Noranco, Lugano, Switzerland","institution_ids":["https://openalex.org/I4210152331"]},{"raw_affiliation_string":"IBSA Institut Biochimque S.A., Pambio-Noranco, Lugano, Switzerland","institution_ids":["https://openalex.org/I4210152331"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027823359","display_name":"Milko Massimiliano Radicioni","orcid":"https://orcid.org/0000-0002-3940-8375","observed_orcids":["https://orcid.org/0000-0002-3940-8375"]},"institutions":[{"id":"https://openalex.org/I4405267631","display_name":"CROSS Research SA (Switzerland)","ror":"https://ror.org/03nqjwm69","country_code":"CH","type":"company","lineage":["https://openalex.org/I4405267631"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Milko Radicioni","raw_affiliation_strings":["CROSS Research S.A., Via F.A. Giorgioli 14, 6864, Arzo, Switzerland","CROSS Research S.A., Arzo, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CROSS Research S.A., Via F.A. Giorgioli 14, 6864, Arzo, Switzerland","institution_ids":["https://openalex.org/I4405267631"]},{"raw_affiliation_string":"CROSS Research S.A., Arzo, Switzerland","institution_ids":["https://openalex.org/I4405267631"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5030190033"],"corresponding_institution_ids":["https://openalex.org/I4405267631"],"apc_list":{"value":4190,"currency":"USD","value_usd":4190},"apc_paid":{"value":4190,"currency":"USD","value_usd":4190},"fwci":2.3357,"has_fulltext":true,"cited_by_count":30,"citation_normalized_percentile":{"value":0.87711098,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"38","issue":"8","first_page":"765","last_page":"772"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10459","display_name":"Sexual function and dysfunction studies","score":0.6532999873161316,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10459","display_name":"Sexual function and dysfunction studies","score":0.6532999873161316,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.09000000357627869,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.08420000225305557,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sildenafil","display_name":"sildenafil","score":0.9120000004768372},{"id":"https://openalex.org/keywords/orodispersible-films","display_name":"orodispersible films","score":0.9710000157356262},{"id":"https://openalex.org/keywords/sublingual-administration","display_name":"sublingual administration","score":0.9259999990463257},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.7160000205039978},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9589999914169312},{"id":"https://openalex.org/keywords/erectile-dysfunction","display_name":"erectile dysfunction","score":0.9449999928474426},{"id":"https://openalex.org/keywords/sildenafil-citrate","display_name":"sildenafil citrate","score":0.9480000138282776},{"id":"https://openalex.org/keywords/drug-delivery-route-comparison","display_name":"drug delivery route comparison","score":0.44699999690055847},{"id":"https://openalex.org/keywords/headache","display_name":"headache","score":0.375},{"id":"https://openalex.org/keywords/vomiting","display_name":"vomiting","score":0.5210000276565552}],"concepts":[{"id":"https://openalex.org/C2776768464","wikidata":"https://www.wikidata.org/wiki/Q191521","display_name":"Sildenafil","level":2,"score":0.8954732418060303},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.884044885635376},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7343281507492065},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5926666259765625},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.4836903214454651},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.41765278577804565},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23852387070655823}],"mesh":[{"descriptor_ui":"D000068677","descriptor_name":"Sildenafil Citrate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000068677","descriptor_name":"Sildenafil Citrate","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000068677","descriptor_name":"Sildenafil Citrate","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000286","descriptor_name":"Administration, Sublingual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004339","descriptor_name":"Drug Compounding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014665","descriptor_name":"Vasodilator Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014665","descriptor_name":"Vasodilator Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014665","descriptor_name":"Vasodilator Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1007/s40261-018-0665-x","doi":"https://doi.org/10.1007/s40261-018-0665-x","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40261-018-0665-x","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40261-018-0665-x.pdf","source":{"id":"https://openalex.org/S138241747","display_name":"Clinical Drug Investigation","issn_l":"0114-2402","issn":["0114-2402","1173-2563","1179-1918","2196-4920"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Drug Investigation","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5031067","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6061399","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:29909432","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29909432","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical drug investigation","raw_type":"Comparative Study"},{"id":"pmh:oai:pubmedcentral.nih.gov:6061399","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6061399/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Drug Investig","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1007/s40261-018-0665-x","doi":"https://doi.org/10.1007/s40261-018-0665-x","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40261-018-0665-x","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40261-018-0665-x.pdf","source":{"id":"https://openalex.org/S138241747","display_name":"Clinical Drug Investigation","issn_l":"0114-2402","issn":["0114-2402","1173-2563","1179-1918","2196-4920"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Drug Investigation","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2808356540.pdf","grobid_xml":"https://content.openalex.org/works/W2808356540.grobid-xml"},"referenced_works_count":17,"referenced_works":["https://openalex.org/W22857079","https://openalex.org/W1484324193","https://openalex.org/W1558292706","https://openalex.org/W1558901950","https://openalex.org/W1879099940","https://openalex.org/W1974840083","https://openalex.org/W2027202120","https://openalex.org/W2052153499","https://openalex.org/W2057210592","https://openalex.org/W2081228674","https://openalex.org/W2088627789","https://openalex.org/W2118462346","https://openalex.org/W2126136540","https://openalex.org/W2314099628","https://openalex.org/W2607212163","https://openalex.org/W3109349661","https://openalex.org/W4211157510"],"related_works":["https://openalex.org/W2792197840","https://openalex.org/W4416553975","https://openalex.org/W2056902051","https://openalex.org/W2075226660","https://openalex.org/W2144521788","https://openalex.org/W2607212163","https://openalex.org/W4400587904","https://openalex.org/W2810793172","https://openalex.org/W2092475147","https://openalex.org/W4392461985"],"abstract_inverted_index":{"Sildenafil":[0],"was":[1,35,76,185],"the":[2,8,41,68,103,121,139,152,157,162,181,222,244],"first":[3],"selective":[4],"drug":[5],"available":[6],"on":[7],"market":[9],"as":[10],"oral":[11,247],"therapy":[12],"for":[13,23],"erectile":[14],"dysfunction":[15],"(ED).":[16],"A":[17],"novel":[18,42],"sildenafil":[19,27,38,65,75,124,211,231],"orodispersible":[20],"film":[21],"(ODF)":[22],"ED":[24,251],"treatment,":[25],"containing":[26],"citrate,":[28],"has":[29],"recently":[30,229],"been":[31],"marketed.":[32],"Study":[33],"objective":[34],"to":[36,79,134,156,164,194,243],"investigate":[37],"bioavailability":[39],"of":[40,109,123,178,180,198,210,224],"ODF":[43,212],"formulation":[44],"after":[45],"sublingual":[46,69,206],"and":[47,70,89,100,113,136,200,207,220],"supralingual":[48,71,114,208],"administration.":[49],"In":[50,203],"this":[51],"randomised,":[52],"two-way":[53],"cross-over":[54],"study,":[55],"12":[56,80],"healthy":[57,204],"male":[58],"volunteers":[59],"received":[60],"a":[61,215,240],"single":[62],"50":[63],"mg":[64],"dose":[66],"by":[67,107,234],"administration":[72,105,115,183,209],"routes.":[73],"Plasma":[74],"determined":[77],"up":[78],"h":[81],"post-dose.":[82],"Peak":[83],"concentration":[84],"(":[85,173],"C":[86,143,166],"max":[87,144,167],")":[88,97],"area":[90],"under":[91],"concentration-time":[92],"curve":[93],"(AUC":[94],"0\u2013":[95,128],"t":[96,129],"were":[98,137,148,192],"calculated":[99],"compared":[101],"between":[102,171],"two":[104,182],"routes":[106,184],"analysis":[108],"variance":[110],"(ANOVA).":[111],"Sublingual":[112],"can":[116,238],"be":[117],"claimed":[118],"equivalent":[119],"regarding":[120],"extent":[122],"exposure":[125,179],"since":[126],"AUC":[127],"90":[130],"%":[131],"CIs":[132,146],"corresponded":[133],"94.90\u2013110.58%":[135],"within":[138],"pre-specified":[140],"acceptance":[141],"range.":[142],"90%":[145],"(79.92\u2013125.57%)":[147],"only":[149],"slightly":[150],"outside":[151],"80.00\u2013125.00%":[153],"limits,":[154],"due":[155],"small":[158],"sample":[159],"size,":[160],"while":[161],"time":[163],"achieve":[165],"did":[168],"not":[169],"differ":[170],"treatments":[172],"p":[174],"=":[175],"0.9277).":[176],"Rate":[177],"therefore":[186],"similar.":[187],"Reported":[188],"treatment-related":[189],"adverse":[190],"events":[191],"mild":[193],"moderate":[195],"headache":[196],"(33.3%":[197],"subjects)":[199],"vomiting":[201],"(8.3%).":[202],"men,":[205],"resulted":[213],"in":[214,250],"remarkably":[216],"similar":[217],"pharmacokinetic":[218],"profile":[219],"confirmed":[221],"safety":[223],"both":[225,235],"study":[226],"treatments.":[227],"The":[228],"marketed":[230,245],"ODF,":[232],"administered":[233],"investigated":[236],"routes,":[237],"provide":[239],"valuable":[241],"alternative":[242],"solid":[246],"forms":[248],"(tablets)":[249],"treatment.":[252]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2018-06-21T00:00:00"}